NM_181426.2:c.1620C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_181426.2(CCDC39):c.1620C>T(p.Ile540Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,544,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000017   (  0   hom.  ) 
Consequence
 CCDC39
NM_181426.2 synonymous
NM_181426.2 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.78  
Publications
1 publications found 
Genes affected
 CCDC39  (HGNC:25244):  (coiled-coil domain 39 molecular ruler complex subunit) The protein encoded by this gene is involved in the motility of cilia and flagella. The encoded protein is essential for the assembly of dynein regulatory and inner dynein arm complexes, which regulate ciliary beat. Defects in this gene are a cause of primary ciliary dyskinesia type 14 (CILD14). [provided by RefSeq, Jul 2011] 
CCDC39 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 14Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52). 
BP6
Variant 3-180644165-G-A is Benign according to our data. Variant chr3-180644165-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 525478.Status of the report is criteria_provided_single_submitter, 1 stars. 
BP7
Synonymous conserved (PhyloP=1.78 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000132  AC: 2AN: 151936Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
151936
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000196  AC: 3AN: 153086 AF XY:  0.0000247   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
3
AN: 
153086
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000165  AC: 23AN: 1392066Hom.:  0  Cov.: 29 AF XY:  0.0000218  AC XY: 15AN XY: 686530 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
23
AN: 
1392066
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
15
AN XY: 
686530
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
31360
American (AMR) 
 AF: 
AC: 
2
AN: 
34866
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25086
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
35204
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
77736
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
48668
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5676
European-Non Finnish (NFE) 
 AF: 
AC: 
16
AN: 
1075806
Other (OTH) 
 AF: 
AC: 
3
AN: 
57664
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.427 
Heterozygous variant carriers
 0 
 1 
 2 
 4 
 5 
 6 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000132  AC: 2AN: 152054Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74326 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152054
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
2
AN XY: 
74326
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41504
American (AMR) 
 AF: 
AC: 
0
AN: 
15252
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10558
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
67962
Other (OTH) 
 AF: 
AC: 
1
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.475 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Primary ciliary dyskinesia    Benign:1 
Feb 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.